Clinical Trial Update: Biomarkers In Retinitis Pigmentosa (BIRP)

View source ↗

Summary

This clinical trial update notes the completion of a Johns Hopkins study investigating biomarkers in Retinitis Pigmentosa under the BIRP program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Snippet

Sponsor: Johns Hopkins University | Conditions: Retinitis Pigmentosa | Status: COMPLETED